Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7632924 Antigen-binding polypeptides and their uses

Patent 7632924 was granted and assigned to Ambrx on December, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Feng Tian0

Ho Sung Cho0

Lillian Ho0

Thomas O. Daniel0

Thomas P. Cujec0

Troy E. Wilson0

Anna-Maria Hays0

Bruce E. Kimmel0

Date of Patent

December 15, 2009

0

Patent Application Number

111559090

Date Filed

June 17, 2005

0

Patent Citations Received

US Patent 12122840 Method of modifying isoelectric point of antibody via amino acid substitution in CDR

0

US Patent 11680104 Anti-LAG-3 antibodies

0

US Patent 11708413 Anti-CD74 antibody conjugates, compositions comprising anti-CD74 antibody conjugates and methods of using anti-CD74 antibody conjugates

0

US Patent 11780912 Composition for prophylaxis or treatment of IL-8 related diseases

US Patent 11786578 Modified relaxin polypeptides and their uses

US Patent 11958909 Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use

0

US Patent 12116414 Method of modifying isoelectric point of antibody via amino acid substitution in CDR

0

Patent Primary Examiner

Stephen L. Rawlings

0

Patent abstract

Novel antigen-binding polypeptides (ABP) and uses thereof are provided.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7632924 Antigen-binding polypeptides and their uses

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool